5-Fluorouracil/folinic acid chronomodulated dose-findig in elderly advanced colorectal patients.

被引：0
|
作者：
Iaffaioli, RV
Tortoriello, A
Facchini, G
Turito, G
Frattolillo, A
Lombardi, R
Santangelo, M
Ciccarelli, PD
De Rosa, P
Benassai, G
Barbarisi, A
机构：
[1] Univ Cagliari, Cattedra Oncol Clin, I-09124 Cagliari, Italy
[2] Univ Catanzaro, Catanzaro, Italy
[3] Univ Naples Federico II, Naples, Italy
[4] Univ Naples 2, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
H32
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [1] Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients
    Garufi, C
    Brienza, S
    Pugliese, P
    Aschelter, AM
    Bensmaine, MA
    Bertheault-Cvitkovic, F
    Nisticò, C
    Giunta, S
    Caterino, M
    Giannarelli, D
    Cosimelli, M
    Lévi, F
    Terzoli, E
    ANTI-CANCER DRUGS, 2000, 11 (06) : 495 - 501
  • [2] Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: Lack of activity in advanced colorectal cancer
    Natoli, C
    Scognamiglio, MT
    Martino, MT
    Irtelli, L
    De Tursi, M
    Cianchetti, E
    Mascitelli, E
    Tinari, N
    Iacobelli, S
    ANTICANCER RESEARCH, 2000, 20 (2B) : 1253 - 1256
  • [3] Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acid in the treatment of patients with advanced colorectal carcinoma -: A phase I study
    Garufi, G
    Dogliotti, L
    D'Attino, RM
    Tampellini, M
    Aschelter, AM
    Pugliese, P
    Perrone, M
    Nisticó, C
    Comis, S
    Terzoli, E
    CANCER, 2001, 91 (04) : 712 - 720
  • [4] A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
    Garufi, C
    Bria, E
    Vanni, B
    Zappalà, AMR
    Sperduti, I
    Terzoli, E
    BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1870 - 1875
  • [5] A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
    C Garufi
    E Bria
    B Vanni
    A M R Zappalà
    I Sperduti
    E Terzoli
    British Journal of Cancer, 2003, 89 : 1870 - 1875
  • [6] High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in elderly patients with advanced colorectal cancer
    Recchia, F
    De Filippis, S
    Saggio, G
    Rosselli, M
    Guerriero, G
    Rea, S
    ANNALS OF ONCOLOGY, 1998, 9 : 80 - 80
  • [7] Chronomodulated infusion of 5-fluorouracil, folinic acid and carboplatin in colorectal cancer: A pilot study
    Natoli, C
    Martino, MT
    Irtelli, L
    DOstilio, N
    Basilico, L
    Iacobelli, S
    ANTICANCER RESEARCH, 1995, 15 (6B) : 2841 - 2842
  • [8] High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5–16) in advanced colorectal cancer patients
    Edmondo Terzoli
    Carlo Garufi
    Albina Rita Zappalà
    Barbara Vanni
    Patrizia Pugliese
    Giancarlo Antonini Cappellini
    Anna Maria Aschelter
    Maria Perrone
    Diana Giannarelli
    Journal of Cancer Research and Clinical Oncology, 2004, 130 : 445 - 452
  • [9] High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5-16) in advanced colorectal cancer patients
    Terzoli, E
    Garufi, C
    Zappalà, AR
    Vanni, B
    Pugliese, P
    Cappellini, GA
    Aschelter, AM
    Perrone, M
    Giannarelli, D
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (08) : 445 - 452
  • [10] Chronomodulated infusion of irinotecan, 5-fluorouracil and folinic acid and hematological toxicity in patients with advanced gastrointestinal cancer
    Merkel, U
    Farker, K
    Wedding, U
    Hippius, M
    Höffken, K
    Hoffmann, A
    MEDIZINISCHE KLINIK, 2006, 101 (04) : A45 - A45
12345